LALiss Anda

Liss Anda

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Liss Anda has a total of 51 co-authors. Here are the top co-authors by number of shared publications:

  • Inge Joa

    TIPS, Centre for Clinical Research in Psychosis, Stavanger University Hospital, Stavanger, Norway; Institute of Public Health, Faculty of Health Sciences, University of Stavanger, Stavanger, Norway

    6 shared publications
  • Jan Olav Johannessen

    TIPS Network for Clinical Psychosis Research, Stavanger University Hospital, Stavanger, Norway

    4 shared publications
  • Johannes Langeveld

    Psychiatric Division, Network of Clinical Psychosis Research, Stavanger University Hospital, 4068 Stavanger, Norway

    4 shared publications
  • Else-Marie Løberg

    NORMENT, Division of Psychiatry, Haukeland University Hospital, Bergen, Norway

    3 shared publications
  • Erik Johnsen

    NORMENT, Division of Psychiatry, Haukeland University Hospital, Bergen, Norway

    3 shared publications
  • Maria Rettenbacher

    Research Department, Division of Psychiatry

    3 shared publications

Latest Publications

  • Open Access

    Norske kvinners opplevelser av hva som var hjelpsomt for tilfriskning fra fødselsdepresjon

    by Frida Sætre, Lynn Watson, Liss Anda

    Fødselsdepresjon (FD) rammer rundt 10 % av norske kvinner. Vi vet lite om hva som fremmer tilfriskning fra FD, spesielt fra perspektivet til kvinner med FD. Målet med studien var å undersøke hva kvinner opplever at fremmer tilfriskning fra FD. Vi analyserte semistrukturerte intervju med 10 kvinner som hadde opplevd FD i de siste 5 årene, med refleksiv tematisk analyse. Fire temaer ble skapt: «Å holde babyen er å holde mor: Praktisk hjelp og avlastning som nøkkel til tilfriskning», «Fra depressiv skam til gjenoppbygging av livet, via åpenhet og relasjon», «Å anerkjenne og ivareta egne basalbehov er nødvendig for tilfriskning» og «Mer enn bare en mamma: Å integrere et mestrende, ikke-moderlig selv i ny identitet etter FD». Funnene kan bidra til vår forståelse av hva kvinner med FD opplever som hjelpsomt i tilfriskning, og kan informere klinisk praksis. Nøkkelord: fødselsdepresjon, bedring, refleksiv tematisk analyse


  • Reply to a Letter to the Editors From Dr de Souza and colleagues: “Unraveling the Optimal Treatment Approach for Depression in Schizophrenia Spectrum: A Quest for Clarity”

    by Eirik Kjelby, Rolf Gjestad, Farivar Fathian, Igne Sinkeviciute, Renata Alisauskiene, Liss-Gøril Anda, Else-Marie Løberg, Solveig Klæbo Reitan, Inge Joa, Tor Ketil Larsen, et al.


  • Open Access

    Antidepressive Effectiveness of Amisulpride, Aripiprazole, and Olanzapine in Patients With Schizophrenia Spectrum Disorders

    by Eirik Kjelby, Rolf Dr Philos Gjestad, Farivar Fathian, Igne Sinkeviciute, Renata Alisauskiene, Liss Anda, Else-Marie Løberg, Solveig Klæbo Reitan, Inge Joa, Tor Ketil Larsen, et al.

    Background: Depressive symptoms are frequent in schizophrenia and associated with a poorer outcome. Currently, the optimal treatment for depressive symptoms in schizophrenia remains undetermined. Amisulpride, aripiprazole, and olanzapine all have antidepressive pharmacodynamic properties, ranging from serotonergic affinities to limbic dopaminergic selectivity. Consequently, in a 12-month pragmatic, randomized clinical trial, we aimed to investigate differences in antidepressive effectiveness among amisulpride, aripiprazole, and olanzapine as a secondary outcome, measured by change in the Calgary Depression Scale for Schizophrenia sum score in patients within the schizophrenia spectrum. Methods: Psychotic patients within the schizophrenia spectrum were included, and effectiveness was analyzed with latent growth curve modeling. Results: Of the 144 patients, 51 (35%) were women, the mean age was 31.7 (SD 12.7), and 39% were antipsychotic naive. At inclusion, 68 (47%) participants had a Calgary Depression Scale for Schizophrenia sum score >6, indicating severe depressive symptoms. Across the 12-month follow-up, there was a depressive symptom reduction in all medication groups, but no statistically significant differences between the study drugs. Separate analyses of the subcohort with elevated depressive symptoms at inclusion also failed to find differences in depressive symptom reduction between study drugs. The reduction in depressive symptoms mainly occurred within 6 weeks after randomization. Conclusions: There was a reduction in depressive symptoms under treatment with amisulpride, aripiprazole, and olanzapine in acutely psychotic patients with schizophrenia spectrum disorder, but no differences between the drugs.


  • Open Access

    Cognitive change and antipsychotic medications: Results from a pragmatic rater-blind RCT

    by Liss Anda, Erik Johnsen, Rune A. Kroken, Inge Joa, Maria Rettenbacher, Else-Marie Løberg


  • Open Access

    Cognitive Profile in Ultra High Risk for Psychosis and Schizophrenia: A Comparison Using Coordinated Norms

    by Liss Anda, Kolbjørn K. Brønnick, Jan Olav Johannessen, Inge Joa, Rune A. Kroken, Erik Johnsen, Maria Rettenbacher, Farivar Fathian, Else-Marie Løberg

    Background: Cognitive impairment is not only a core aspect of schizophrenia but also commonly observed in help-seeking youth at ultra high risk for psychosis (UHR), with potential implications for prognosis and individualized treatment. However, there is no consensus on the cognitive profile in the UHR state, partly due to lack of valid comparisons of performance in established schizophrenia and UHR. Objectives: To compare the cognitive functioning and profile of UHR subjects to a sample with schizophrenia, they were split into two groups based on duration of illness. Comparisons were made using coordinated norms based on healthy controls reflecting the younger UHR age spectrum. Methods: Participants for UHR (n = 51) and schizophrenia groups (n = 19 and n = 22) were included from the Prevention of Psychosis and Bergen Psychosis 2 projects. All subjects completed a comprehensive neurocognitive test battery aiming to measure speed of processing, working memory, verbal learning, reasoning, and problem solving, as well as visual problem solving. Cognitive functioning was compared between groups based on coordinated norms using z-scores derived by regression modeling from an age-matched healthy control group (n = 61). Results: UHR subjects showed significantly impaired speed of processing (p < 0.001) working memory (p = 0.042) and verbal learning, reasoning, and problem solving (p = 0.007) as compared to the control group. Visual problem-solving skills appeared unimpaired. UHR subjects significantly outperformed the schizophrenia group with duration of illness >3 years for speed of processing and working memory (both p < 0.001). There were no significant differences in performance between the UHR group and the group with duration of schizophrenia Conclusion: Cognitive performance is impaired in UHR subjects as compared to healthy controls and should thus be monitored when a person is deemed at high risk of psychotic illness. Spatial skills, as measured by tests using physical objects, appear less affected than other domains. The pattern of impairment is similar to that of a group with recent onset schizophrenia but is less severe than in a group with duration of illness <3 years.


  • Public attitudes towards involuntary admission and treatment by mental health services in Norway

    by Inge Joa, Kjetil Hustoft, Liss Gøril Anda, Kolbjørn Brønnick, Olav Nielssen, Jan Olav Johannessen, Johannes H. Langeveld


  • Open Access

    The Course of Neurocognitive Changes in Acute Psychosis: Relation to Symptomatic Improvement

    by Liss Anda, Kolbjørn S. Brønnick, Erik Johnsen, Rune A. Kroken, Hugo Jørgensen, Else-Marie Løberg

    Cognitive impairment is a core aspect of psychosis, but the course of cognitive functioning during acute psychosis remains poorly understood, as does the association between symptom change and neurocognitive change. Some studies have found cognitive improvement to be related to improvement in negative symptoms, but few have examined cognitive changes in the early acute phase, when clinical improvement mainly happens. This study’s aim was to investigate the relation between cognitive and symptomatic change in clinically heterogeneous patients during the early acute phase of psychosis. Participants (n = 84), including both first-episode and previously ill patients, were recruited from consecutive admissions to the acute psychiatric emergency ward of Haukeland University Hospital, Bergen, Norway, as part of the Bergen Psychosis Project (BPP). The RBANS neurocognitive test battery was administered on admission and again at discharge from the acute ward (mean time 4.1 weeks, SD 1.86 weeks). Symptomatic change was measured by PANSS. The proportion of subjects with cognitive impairment (t < 35) was 28.6% in the acute phase and 13.1% at follow-up. A sequential multiple linear regression model with RBANS change as the dependent variable found PANSS negative symptoms change to significantly predict total RBANS performance improvement (beta = -.307, p = .016). There was no significant difference between subjects with schizophrenia and those with other psychotic disorders in terms of cognitive change. The proportion of subjects with mild to moderate impairment in cognitive test performance is reduced across the acute phase of psychosis, with improvement related to amelioration of negative symptoms.


  • Open Access

    “Everyone Needs a Friend Sometimes” – Social Predictors of Long-Term Remission In First Episode Psychosis

    by Jone Bjornestad, Inge Joa, Tor K. Larsen, Johannes Langeveld, Larry Davidson, Wenche Ten Velden Hegelstad, Liss G. Anda, Marius Veseth, Ingrid Melle, Jan O. Johannessen, et al.

    Background Predictors of long-term symptomatic remission are crucial to the successful tailoring of treatment in first episode psychosis. There is lack of studies distinguishing the predictive effects of different social factors. This prevents a valid evaluating of their independent effects. Objectives To test specific social baseline predictors of long-term remission. We hypothesized that first, satisfaction with social relations predicts remission; second, that frequency of social interaction predicts remission; and third, that the effect of friend relationship satisfaction and frequency will be greater than that of family relations satisfaction and frequency. Material and Methods A sample of first episode psychosis (n=186) completed baseline measures of social functioning, as well as clinical assessments. We compared groups of remitted and non-remitted individuals using generalized estimating equations analyses. Results Frequency of social interaction with friends was a significant positive predictor of remission over a two-year period. Neither global perceived social satisfaction nor frequency of family interaction showed significant effects. Conclusions The study findings are of particular clinical importance since frequency of friendship interaction is a possibly malleable factor. Frequency of interaction could be affected through behavioral modification and therapy already from an early stage in the course, and thus increase remission rates. Keywords First-Episode Psychosis, Schizophrenia, Social factors, Baseline predictors, Long-term remission.


  • Open Access

    Visual Hallucinations in First-Episode Psychosis: Association with Childhood Trauma

    by Martine Solesvik, Inge Joa, Tor Ketil Larsen, Johannes Langeveld, Jan Olav Johannessen, Jone Bjørnestad, Liss Gøril Anda, Jens Gisselgård, Wenche Ten Velden Hegelstad, Kolbjørn Brønnick

    Hallucinations are a core diagnostic criterion for psychotic disorders and have been investigated with regard to its association with childhood trauma in first-episode psychosis samples. Research has largely focused on auditory hallucinations, while specific investigations of visual hallucinations in first-episode psychosis remain scarce. The aims of this study were to describe the prevalence of visual hallucinations, and to explore the association between visual hallucination and childhood trauma in a first-episode psychosis sample. Subjects were included from TIPS-2, a first episode psychosis study in south Rogaland, Norway. Based on the medical journal descriptions of the Positive and Negative Symptoms Scale (PANSS), a separate score for visual and auditory hallucinations was created (N = 204). Patients were grouped according to hallucination severity (none, mild, and psychotic hallucinations) and multinomial logistic regression was performed to identify factors associated with visual hallucination group. Visual hallucinations of a psychotic nature were reported by 26.5% of patients. The experience of childhood interpersonal trauma increased the likelihood of having psychotic visual hallucinations. Visual hallucinations are common in first-episode psychosis, and are related to childhood interpersonal trauma.


  • Verbal working memory deficits predict levels of auditory hallucination in first-episode psychosis

    by Jens Gisselgård, Liss Gøril Anda, Kolbjørn Brønnick, Johannes Langeveld, Wenche Ten Velden Hegelstad, Inge Joa, Jan Olav Johannessen, Tor Ketil Larsen